Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 16.76%-7.6M | ---- | 36.01%-9.13M | ---- | -390.00%-14.26M | ---- | -5,117.24%-2.91M | ---- | 100.35%58K |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -858.33%-115K | ---- | 0.00%-12K | ---- | 86.52%-12K | ---- | 53.89%-89K | ---- | 59.11%-193K |
| Impairment and provisions: | ---- | -70.04%438K | ---- | 31.95%1.46M | ---- | -27.25%1.11M | ---- | 434.73%1.52M | ---- | -4.36%-455K |
| -Impairment of trade receivables (reversal) | ---- | -70.04%438K | ---- | 31.95%1.46M | ---- | -27.25%1.11M | ---- | 565.75%1.52M | ---- | 29.83%-327K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -526.67%-128K |
| Revaluation surplus: | ---- | 45.65%-25K | ---- | -206.67%-46K | ---- | -275.00%-15K | ---- | ---4K | ---- | ---- |
| -Other fair value changes | ---- | 45.65%-25K | ---- | -206.67%-46K | ---- | -275.00%-15K | ---- | ---4K | ---- | ---- |
| Asset sale loss (gain): | ---- | 73.56%-527K | ---- | -347.87%-1.99M | ---- | 72.50%-445K | ---- | ---1.62M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 101.55%2K | ---- | -6,550.00%-129K | ---- | 101.39%2K | ---- | ---144K | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | 71.62%-529K | ---- | -317.00%-1.86M | ---- | 69.67%-447K | ---- | ---1.47M | ---- | ---- |
| Depreciation and amortization: | ---- | -12.28%793K | ---- | 27.86%904K | ---- | 32.40%707K | ---- | -35.97%534K | ---- | -25.40%834K |
| Financial expense | ---- | -20.95%83K | ---- | 50.00%105K | ---- | 1,300.00%70K | ---- | -54.55%5K | ---- | -66.67%11K |
| Special items | ---- | ---2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,576.27%-1.46M |
| Operating profit before the change of operating capital | ---- | 20.15%-6.95M | ---- | 32.24%-8.71M | ---- | -401.99%-12.85M | ---- | -112.19%-2.56M | ---- | 92.67%-1.21M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -92.17%464K | ---- | -25.97%5.93M | ---- | 287.20%8M | ---- | 29.30%-4.28M | ---- | -281.92%-6.05M |
| Accounts payable increase (decrease) | ---- | 75.55%-289K | ---- | -231.33%-1.18M | ---- | 182.04%900K | ---- | 69.60%-1.1M | ---- | 59.99%-3.61M |
| prepayments (increase)decrease | ---- | 533.93%243K | ---- | -106.19%-56K | ---- | 502.22%905K | ---- | -1,150.00%-225K | ---- | 92.80%-18K |
| Cash from business operations | ---- | -62.59%-6.53M | ---- | -32.26%-4.02M | ---- | 62.75%-3.04M | ---- | 25.04%-8.16M | ---- | 51.40%-10.88M |
| Special items of business | -110.31%-1.37M | ---- | 63.63%-650K | ---- | -221.48%-1.79M | ---- | 203.23%1.47M | ---- | 83.85%-1.43M | ---300K |
| Net cash from operations | -110.31%-1.37M | -62.59%-6.53M | 63.63%-650K | -32.26%-4.02M | -221.48%-1.79M | 62.75%-3.04M | 203.23%1.47M | 27.05%-8.16M | 83.85%-1.43M | 50.06%-11.18M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 858.33%115K | ---- | 0.00%12K | ---- | -86.52%12K | ---- | -53.89%89K | ---- | -48.94%193K |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20.47%9.79M | ---- | 31.48%8.12M |
| Sale of fixed assets | ---- | ---- | ---- | 2,980.00%154K | ---- | -97.22%5K | ---- | --180K | ---- | ---- |
| Purchase of fixed assets | ---- | ---- | ---- | 81.25%-6K | ---- | -300.00%-32K | ---- | 82.22%-8K | ---- | ---45K |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.77M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.13M |
| Recovery of cash from investments | ---- | -71.35%4.05M | ---- | 68.24%14.12M | ---- | --8.39M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 0.99%-10M | ---- | -7.10%-10.1M | ---- | -325.35%-9.43M | ---- | 48.25%-2.22M | ---- | ---4.28M |
| Other items in the investment business | 15,792.06%10.01M | ---- | -70.28%63K | ---- | 1,614.29%212K | ---- | -100.20%-14K | ---- | -4.38%6.95M | ---- |
| Net cash from investment operations | 15,792.06%10.01M | -239.81%-5.84M | -70.28%63K | 496.30%4.18M | 1,614.29%212K | -110.98%-1.05M | -100.20%-14K | 235.64%9.6M | -4.38%6.95M | -56.81%2.86M |
| Net cash before financing | 1,572.74%8.65M | -7,881.76%-12.37M | 62.73%-587K | 103.89%159K | -208.10%-1.58M | -384.17%-4.09M | -73.61%1.46M | 117.31%1.44M | 453.46%5.52M | 47.23%-8.32M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 10,800.00%10.9M | ---- | -98.75%100K | ---- | --8M | ---- | ---- | ---- | --5M |
| Refund | ---- | ---1M | ---- | ---- | ---- | ---5M | ---- | ---- | ---- | ---- |
| Other items of the financing business | -581.46%-8.75M | ---- | -804.23%-1.28M | ---- | 95.27%-142K | ---- | -3,125.81%-3M | ---- | 77.26%-93K | ---- |
| Net cash from financing operations | -581.46%-8.75M | 1,998.38%9.4M | -804.23%-1.28M | -118.04%-495K | 95.27%-142K | 2,163.16%2.74M | -3,125.81%-3M | -102.94%-133K | 77.26%-93K | 306.94%4.52M |
| Effect of rate | 265.68%991K | 836.36%81K | 375.44%271K | -102.67%-11K | -80.34%57K | 376.51%412K | 1,135.71%290K | 30.70%-149K | -131.46%-28K | -218.13%-215K |
| Net Cash | 94.39%-105K | -785.71%-2.98M | -8.97%-1.87M | 75.07%-336K | -11.28%-1.72M | -203.14%-1.35M | -128.43%-1.54M | 134.36%1.31M | 375.39%5.43M | 74.05%-3.8M |
| Begining period cash | -45.35%3.49M | -5.16%6.38M | -5.16%6.38M | -12.21%6.73M | -12.21%6.73M | 17.79%7.67M | 17.79%7.67M | -38.17%6.51M | -38.17%6.51M | -57.90%10.53M |
| Cash at the end | -8.55%4.38M | -45.35%3.49M | -5.66%4.78M | -5.16%6.38M | -20.94%5.07M | -12.21%6.73M | -46.14%6.41M | 17.79%7.67M | 37.74%11.91M | -38.17%6.51M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.